Evidence map›Paper›PMID 40739426›Full record

ArticleEJNMMI radiopharmacy and chemistry2025

Minimising the impact of stable

Rachel Roberts, Tim Carthy, Jennifer Young, Temi Awogboro, Howard Greenwood, Jane Sosabowski, Scott Heath, Francis Livens

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel RobertsDepartment of Chemistry, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK. rachel.roberts-2@student.manchester.ac.uk.ORCID http://orcid.org/0000-0002-3398-0821
Tim CarthyUnited Kingdom National Nuclear Laboratory, Springfields, Salwick, Preston, Lancashire, PR4 0XJ, UK.
Jennifer YoungCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID http://orcid.org/0000-0002-4141-9663
Temi AwogboroUnited Kingdom National Nuclear Laboratory, Springfields, Salwick, Preston, Lancashire, PR4 0XJ, UK.ORCID http://orcid.org/0009-0000-3291-8949
Howard GreenwoodUnited Kingdom National Nuclear Laboratory, Springfields, Salwick, Preston, Lancashire, PR4 0XJ, UK.ORCID http://orcid.org/0009-0009-6588-6133
Jane SosabowskiCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID http://orcid.org/0000-0001-7653-5923
Scott HeathDepartment of Earth and Environmental Sciences, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK.ORCID http://orcid.org/0000-0002-8342-3732
Francis LivensDepartment of Chemistry, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK.ORCID http://orcid.org/0000-0001-9547-1742

Funding

Engineering and Physical Sciences Research Council EP/S032789/1
6 · The paper itself

Abstract

backgroundStable

resultsThe optimal elution time with respect to A

conclusionsThe limited data available in literature shows the level of

Indexed as

LeadMolar activityRadiolabellingSpecific activityStable lead

Identifiers

PMID40739426
PMCPMC12311066

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.